Connect with us

News

FDA approval, fundraising, and the reality of building in healthcare according to BioticsAI founder

info

Published

on

Bms2e11 featured.png

Founders building in the healthcare space can’t just build fast and break things. Timelines stretch longer, stakes are higher, and success depends on navigating systems that reward rigor over speed. 

That’s exactly the reality Robhy Bustami, co-founder and CEO of BioticsAI, has been building in. His company is developing an AI copilot for ultrasound that helps detect fetal abnormalities, an area where misdiagnosis rates remain surprisingly high. Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly regulated space and kept the team motivated while cutting through all the red tape.

BioticsAI started scrappy. The team built an early, functioning version of the product for under $100,000, an almost unheard-of milestone in the medical device world. That prototype helped them win TechCrunch Startup Battlefield in 2023, bringing early visibility and credibility. In January, they gained FDA approval, which means they can begin launching in hospitals and growing the business at a new rate. 

From day one, the team approached product development with FDA approval in mind. Instead of building first and figuring out regulation later, they integrated clinical validation, regulatory strategy, and product development into a single process. That meant working closely with clinicians, collecting large-scale datasets, and running structured clinical studies before ever reaching the submission stage.

The FDA process itself is often viewed as a black box, but Bustami emphasizes that founders don’t have to navigate it blindly. Early engagement with regulators, through pre-submission meetings, helped the team align on study design and expectations. Still, risk never fully disappears. For many investors, the biggest question is simple: What if the FDA says no?

Internally, those long timelines create a different kind of challenge: keeping a team motivated when the biggest milestone is years away. At BioticsAI, that meant building a culture of alignment across engineers, clinicians, and researchers, ensuring everyone got to see the wins that were happening.

 “Making sure everyone is completely aligned, even if it’s outside of their technical scope,” Bustami said, “constantly seeing wins on the R&D side,” from clinical studies to new healthcare partnerships.

Techcrunch event

San Francisco, CA
|
October 13-15, 2026

Now, with FDA clearance secured, BioticsAI is entering a new phase: deployment. The company is beginning to roll out its technology in hospitals, with plans to expand beyond obstetrics into broader areas of reproductive health.

Building in healthcare is a long game. It requires patience, discipline, and a willingness to operate in uncertainty. For founders willing to take that path, the reward isn’t just a successful company — it’s the chance to build something that genuinely changes how care is delivered.


Subscribe to Build Mode on Apple Podcasts, Spotify, or wherever you like to listen. Watch the full videos on YouTube. Isabelle Johannessen is our host. Build Mode is produced and edited by Maggie Nye. Audience Development is led by Morgan Little. And a special thanks to the Foundry and Cheddar video teams. 


Apply to Startup Battlefield: We are looking for early-stage companies that have an MVP. So nominate a founder (or yourself). Be sure to say you heard about Startup Battlefield from the Build Mode podcast. Apply here.

TechCrunch Disrupt 2026: We’re back for TechCrunch Disrupt on October 13 to 15 in San Francisco, where the Startup Battlefield 200 takes the stage. So if you want to cheer them on, or just network with thousands of founders, VCs, and tech enthusiasts, then grab your tickets.

Use code buildmode15 for 15% off any ticket type. 

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Imo senatorial aspirant, Nwachukwu drags NDC to court over ticket denial  

info

Published

on

By

Nwachukwu .jpg

A Senatorial Aspirant, Isaac Nwachukwu, has dragged Nigeria Democratic Congress, NDC, and the Independent National Electoral Commission, INEC, before a Federal High Court Sitting in Owerri, Imo State, over the fallout of the party’s National Assembly primaries.

Nwachukwu, in a suit filed through his Counsel, Cajethan Oguzie, accused the party of denying him the Imo North senatorial ticket after emerging a consensus candidate and paying N5m for the nomination form.

The suit also disclosed that Nwachukwu had paid N20m for the support of the party, but his support was unexplainably reduced to N10m when the list of those who supported the party was published.

The NDC Senatorial Aspirant, in his prayers before the court, demanded that a declaration should be made that he is the consensus candidate of the party in the state with regard to the Imo North Senatorial Zone in the 2027 General election.

“A declaration that the first defendant, NDC, be restrained from fielding another candidate except the plaintiff in the General election into the Imo North Senatorial Zone as he is the consensus candidate for the said election.

“A declaration that the second defendant, INEC, be perpetually restrained from recognising and accepting the candidacy of another person except the plaintiff in the Imo North Senatorial election pending the determination of the matter,” the suit stated.

In an affidavit supporting the originating summons, Nwachukwu stated that he purchased the expression of interest form to aspire for the position for Imo North senatorial zone, a copy of which is attached in the suit already filed.

The NDC Senatorial Aspirant added that upon the purchase of the form, he made a monetary contribution in support of the party’s growth in the tune of N20m into the party’s FCMB account number through his Counsel, receipt also attached in the suit as an exhibit.

“The first sign of irregularity and no compliance with the NDC constitution and electoral act came up when the N20m I paid for party support was allocated to one of the aspirants for my Senatorial District by the name Matthew Omegara, and the N10m that Matthew Omegara paid for party support was allocated to me by the Screening Committee headed by Sam Egwu and Buba Galadimma.

” In compliance with NDC’s directives, I participated in the NDC screening exercise and was successfully cleared as an aspirant to participate in the primary election.

After my consensus candidacy was ratified, my name was shortlisted as a Candidate for Imo North district. A copy of the result is hereby annexed as Exhibit 1U5,” the affidavit added.

Nwachukwu alleged that his name was substituted with Omegara after he had been declared the winner of the primary election.

The Imo North Senatorial Aspirant claimed that the National leader of the party, Seriake Dickson, had summoned him for a meeting telling him that his candidacy was affected after a party chieftain from his state said he didn’t know him.

Among other demands, Nwachukwu is asking the court to order NDC to issue him a certificate as its candidate for the Imo North Senatorial District.

Continue Reading

News

ADC raises alarm over alleged membership forgery in Zamfara

info

Published

on

By

ADC 2.jpg

Supporters and members of the African Democratic Congress, ADC, in Anka and Talata Mafara Local Government Areas of Zamfara State have alleged attempts to manipulate the party’s membership records and card numbers ahead of internal political activities.
The allegation was contained in a statement issued on Wednesday in Gusau by Nura Rabiu Cibiki, Director of Media and Strategy, Campaign and Mobilisation Committee for Abdulrahaman Yahaya, an aspirant for the House of Representatives seat representing Anka/Talata Mafara Federal Constituency.

The group warned against any attempt to alter or duplicate legitimate membership figures, saying such actions could deepen tensions within the party in the constituency.

“We strongly oppose any move to manipulate or duplicate legitimate membership figures, warning that such actions would only worsen existing tensions within the party and the Anka/Talata Mafara Federal Constituency,” the statement said.

The supporters maintained that ADC members in Anka and Talata Mafara were aware of the party’s authentic membership strength and were prepared to protect the integrity of the party’s records.

The statement added that while justice may be delayed, the truth could not be denied.

Meanwhile, Yahaya has filed a suit at the Federal High Court in Gusau challenging alleged irregularities in the party’s primary election process in the constituency.

The court has fixed June 23, 2026, for mention of the case.

Continue Reading

Trending